bluebird bio Inc (BLUE) Transcripts
Q3 2024 bluebird bio Inc Earnings Call Transcript
Nov 14, 2024
$0.3626
(-3.64%)
Earnings
Q2 2024 bluebird bio Inc Earnings Call Transcript
Aug 14, 2024
$0.8149
(-23.12%)
Earnings
Q4 2023 bluebird bio Inc Earnings Call Transcript
Mar 26, 2024
$1.2
(-11.76%)
Earnings
bluebird bio Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2024
Q3 2023 bluebird bio Inc Earnings Call Transcript
Nov 07, 2023
$3.54
(+7.27%)
Earnings
bluebird bio Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Q2 2023 bluebird bio Inc Earnings Call Transcript
Aug 08, 2023
$3.89
(+8.06%)
Earnings
bluebird bio Inc at Goldman Sachs Healthcare Conference Transcript
Jun 12, 2023
bluebird bio Inc at Bank of America Global Healthcare Conference Transcript
May 11, 2023
Q4 2022 bluebird bio Inc Earnings Call Transcript
Mar 29, 2023
$3.26
(-24.54%)
Earnings
bluebird bio Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
bluebird bio Inc at Credit Suisse Healthcare Conference Transcript
Nov 09, 2022
bluebird bio Inc Receives FDA Accelerated Approval for SKYSONA Call Transcript
Sep 19, 2022
bluebird bio Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
bluebird bio Inc Launch Call Transcript
Aug 18, 2022
bluebird bio Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 15, 2022
bluebird bio Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
bluebird bio Inc Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US Investor Call Transcript
Apr 05, 2022
bluebird bio Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
bluebird bio Inc Spotlight on bb1111 for Sickle Cell Disease Conference Call Transcript
Nov 18, 2021
bluebird bio Inc at Bank of America Global Healthcare Conference (Virtual) Transcript
Sep 16, 2021
bluebird bio Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 10, 2021
bluebird bio Inc at Wedbush PacGrow Healthcare Conference (Virtual) Transcript
Aug 11, 2021
Q2 2021 bluebird bio Inc Earnings Call Transcript
Aug 09, 2021
$11.76
(-27.45%)
Earnings
bluebird bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021
bluebird bio Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 19, 2021
bluebird bio Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021
bluebird bio Inc to Provide Updated Findings from Reported Case of Acute Myeloid Leukemia (AML) in LentiGlobin for Sickle Cell Disease (SCD) Gene Therapy Program - Conference Call Transcript
Mar 10, 2021
bluebird bio Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 03, 2021
bluebird bio Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 25, 2021
bluebird bio Inc Temporary Suspension On Phase 1/2 And Phase 3 Studies Of LentiGlobin Gene Therapy For Sickle Cell Disease (bb1111) Corporate Call Transcript
Feb 16, 2021
bluebird bio Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2021
bluebird bio Inc to Separate Oncology Business into Independent Company Conference Call Transcript
Jan 11, 2021
bluebird bio Inc ASH Data Review Conference Call Transcript
Dec 08, 2020
bluebird bio Inc at Barclays Virtual Gene Editing & Gene Therapy Summit Transcript
Nov 16, 2020
bluebird bio Inc at Cowen Immuno-Oncology Next Summit Transcript
Nov 13, 2020
Q3 2020 bluebird bio Inc Earnings Call Transcript
Nov 04, 2020
$37.9
(+7.33%)
Earnings
bluebird bio Inc at Jefferies Cell Therapy Summit Transcript
Oct 06, 2020
bluebird bio Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
Sep 18, 2020
bluebird bio Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2020
bluebird bio Inc at Wells Fargo Virtual Healthcare Conference Transcript
Sep 10, 2020
bluebird bio Inc at Canaccord Genuity Growth Conference (Virtual) Transcript
Aug 12, 2020
bluebird bio Inc Annual Shareholders Meeting Transcript
Jun 18, 2020
bluebird bio Inc EHA Data Review - Call Transcript
Jun 12, 2020
bluebird bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2020
bluebird bio Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 04, 2020
bluebird bio Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 14, 2020
bluebird bio Inc and Bristol-Myers Squibb Co to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call Transcript
May 13, 2020
Bristol-Myers Squibb Co and bluebird bio Inc to Provide Regulatory Update on Idecabtagene Vicleucel - Conference Call Transcript
May 13, 2020
Q1 2020 bluebird bio Inc Earnings Call Transcript
May 11, 2020
$38.99
(+1.60%)
Earnings
bluebird bio Inc Provides Assessment of Impact of COVID-19 - Call Transcript
Mar 26, 2020
bluebird bio Inc at Cowen HealthCare Conference Transcript
Mar 03, 2020
bluebird bio Inc at Leerink Global Healthcare Conference Transcript
Feb 26, 2020
bluebird bio Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2020
bluebird bio Inc at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Transcript
Jan 09, 2020
bluebird bio Inc American Society of Hematology (ASH) Data Review - Call Transcript
Dec 10, 2019
bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa Transcript
Oct 02, 2019
bluebird bio Inc at Morgan Stanley Healthcare Conference Transcript
Sep 11, 2019
bluebird bio Inc at Citi Biotech Conference Transcript
Sep 04, 2019
bluebird bio Inc to Present New Data at the European Hematology Association (EHA) Congress Conference Call Transcript
Jun 14, 2019
bluebird bio Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 11, 2019
bluebird bio Inc at Jefferies Healthcare Conference Transcript
Jun 04, 2019
bluebird bio Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019
bluebird bio Inc Analyst Day Transcript
May 09, 2019
bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mediterranean - PLENARY SESSION: COMMERCIAL STRATEGIES FROM PATHFINDERS IN THE INDUSTRY Transcript
Apr 23, 2019
bluebird bio Inc at Alliance for Regenerative Medicine Cell & Gene Therapy Investor Day Transcript
Mar 21, 2019
bluebird bio Inc at Barclays Global Healthcare Conference Transcript
Mar 14, 2019
bluebird bio Inc at Cowen Health Care Conference Transcript
Mar 12, 2019